OVARIAN CANCER METASTATIC RECURRENT
Clinical trials for OVARIAN CANCER METASTATIC RECURRENT explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CANCER METASTATIC RECURRENT trials appear
Sign up with your email to follow new studies for OVARIAN CANCER METASTATIC RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New targeted cancer drug enters first human trials for Tough-to-Treat tumors
Disease control Recruiting nowThis is the first human study of a new experimental cancer drug called HWK-007. Researchers are testing it in adults with advanced ovarian, endometrial, or non-small cell lung cancers that have stopped responding to standard treatments. The main goals are to find the safest dose …
Matched conditions: OVARIAN CANCER METASTATIC RECURRENT
Phase: PHASE1 • Sponsor: Whitehawk Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope for tough ovarian cancers: experimental combo therapy enters testing
Disease control Recruiting nowThis study is testing whether adding a newer targeted drug called disitamab vedotin to standard chemotherapy and bevacizumab works better for certain high-risk ovarian cancers. It will involve 43 patients whose cancer has specific features (HER2-positive and HRD-negative) and is …
Matched conditions: OVARIAN CANCER METASTATIC RECURRENT
Phase: PHASE2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC